Pharma, Pharmaceutics and Biotechnology Conference

The digital health revolution, Is the right future for pharma, a keynote session that will take a close look at the new healthcare digital innovations such as telemedicine, digital therapeutics, and data analytics in patient engagement, drug development, and overall health-care outcomes.

Understanding Digital Health: The term digital health is broad, referencing the very wide range of technologies that impact health and healthcare delivery. Mobile health applications, wearable devices, telehealth platforms, and digital therapeutics are parts of the spectrum.

Learners will learn how these technologies blur the landscape of patient care and contribute to real-time monitoring- a feature that will help advance proactive health management. Telemedicine and Remote Patient Monitoring: Telemedicine is becoming a daily necessity for the provision of healthcare services, especially during the COVID-19 pandemic.

This session will describe how the advent of telemedicine has made opportunities accessible to care, especially to patients who live in remote locations or those suffering from mobility issues. The participant will best understand the implementation best practices of telehealth solutions and also understand that remote patient monitoring indeed plays a significant role in chronic disease management.

Digital Therapeutics: The term 'Digital Therapeutics' describes evidence-based interventions administered through software that can prevent, manage, or treat a medical condition.

This session will consist of successful case studies and clinical evidence regarding the use of digital therapeutics in various therapeutic areas, from mental health to diabetes management and drug addiction treatment.

The participants will be informed about regulatory considerations and the role of digital therapeutics in current traditional treatment pathways. Data Analytics and

Patient Engagement: The focus of harnessing big data analytics will help in improving patient outcomes and optimizing drug development processes. In this session, big data analytics will explain the ability of exploring the needs of the patient, personalizing treatment and enhancing patient engagement.

Attendees will learn innovative ways in how to apply data analytics in decision-making in clinical trials and post-market surveillance.

Challenges and Future Directions: Although digital health seems quite promising, there are many challenges in dealing with regulatory hurdles, data-privacy issues, and enabling the interoperability of solutions across different digital health offerings.

This session would explore such challenges and future directions by pharma of digital health along with collaboration opportunities between technology companies and pharmaceutical firms.

In this final session, participants will appreciate the new role, which is yet to be defined in this industry, that digital health is set to play.

Join us in discussions on some of the innovative solutions found for more effective care of patients, faster development of a more effective drug, and transformations in healthcare delivery.